Alappan R, Perazella MA, Buller GK, et al. Hyperkalemia in hospitalized
patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med.
1996;124(3):316-320.
Apstein C. Glucose-Insulin-Potassium for accute mycocardial infraction:
remarkable results from a new prospective, randomized trial. Circ.
1998;98:2223–2226.
Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium,
calcium, and fiber and risk of stroke among U.S. men. Circ.
1998;98:1198–1204.
Blackshear JL, Davidman M, Stillman MT. Indentification of risk for renal
insuffciency from nonsteroidal anti-inflammatory drugs. Arch Intern Med.
1983;143(6):1130-1134.
Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of potassium
supplementation on blood pressure in African Americans on a low-potassium
diet. Arch Intern Med. 1996;156:61–72.
Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function:
focus on cyclooxygenase-2-selective inhibition. Am J Med.
1999;107(6A):65S-70S.
Chiu TF, Bullard MJ, Chen JC, Liaw SJ, Ng CJ. Rapid life-threatening
hyperkalemia after addition of amiloride HCL/hydrochlorothiazide to
angiotensin-converting enzyme inhibitor therapy. Ann Emerg Med.
1997;30(5):612-615.
Howes LG. Which drugs affect potassium? Drug Saf.
1995;12(4):240-244.
Luft F, Ekhard ZE, Filer LJ, eds. Present Knowledge in Nutrition. 7th
ed. Washington, DC: ILSI Press; 1996:272–276.
Ganong WF. Review of Medical Physiology. 18th ed. Stamford, Conn:
Appleton & Lange; 1997: 677.
Mahan LK, Arlin MT, eds. Krause's Food, Nutrition, and Diet Therapy.
8th ed. Philadelphia, Pa: WB Saunders Co.; 1992:147, 390.
Matsumura M, Nakashima A, Tofuku Y. Electrolyte disorders following massive
insulin overdose in a patient with type 2 diabetes. Intern Med.
2000;39(1):55-57.
National Research Council: Recommended Dietary Allowances. 10th ed.
Washington, DC: National Academy Press;
1989:255–257.
Pasic S, Flannagan L, Cant AJ. Liposomal amphotericin is safe in bone marrow
transplantation for primary immunodeficiency. Bone Marrow Transplant.
1997;19(12):1229-1232.
Perazella MA. Trimethoprim-induced hyperkalemia: clinical data, mechanism,
prevention and management. Drug Saf. 2000;22(3):227-236.
Perazella M, Mahnensmith R. Hyperkalemia in the elderly. J Gen Intern Med.
1997;12:646–656.
Physicians' Desk Reference. 54th ed. Montvale, NJ: Medical Economics
Co., Inc.; 2000:1215-1218, 2034-2040.
Poirier TI. Reversible renal failure associated with ibuprofen: case report
and review of the literature. Drug Intell Clin Pharm.
1984;18(1):27-32.
Preston RA, Hirsh MJ MD, Oster, JR MD, et al. University of Miami Division of
Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia. Am J
Ther. 1998; 5(2):125-132.
Ray K, Dorman S, Watson R. Severe hyperkalemia due to the concomitant use of
salt substitutes and ACE inhibitors in hypertension: a potentially life
threatening interaction. J Hum Hypertens. 1999;13(10):717-720.
Sacks FM, Willett WC, Smith A, et al. Effect on blood pressure of potassium,
calcium, and magnesium in women with low habitual intake. Hypertens.
1998;31(1):131–138.
Shionoiri H. Pharmacokinetic drug interactions with ACE inhibitors. Clin
Pharmacokinet. 1993;25(1):20-58.
Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium
and potassium on mortality and reinfarction rate of patients with suspected
acute myocardial infarction. Int J Clin Pharmacol Thera.
1996;34:219–225.
Stanbury RM, Graham EM. Systemic corticosteroid therapy
– side effects and their management. Br J
Ophthalmol. 1998;82(6):704-708.
Suter PM. Potassium and Hypertension. Nutrition Reviews.
1998;56:151–133.
Whang R, Oei TO, Watanabe A. Frequency of hypomagnesia in hospitalized
patients receiving digitalis. Arch Intern Med. 1985;145(4):655-656.
Whelton, A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen,
piroxicam, and sulindac in patients with asymptomatic renal failure. A
prospective, randomized, crossover comparison. Ann Intern Med.
1990;112(8):568-576.
Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective
mechanisms. Am J Physiology. 1995;268(part
2):R825–R837.